CRISPR Editing Tool Box Catalog No.:LI30010-2S a multitargeted inhibitor of histone

a multitargeted inhibitor of histone deacetylase

including the premature-aging disease Hutchinson-Gilford progeria syndrome (HGPS)

InChi: InChI=1S/C39H65N5O8/c1-12-25(6)34(43(9)38(48)33(24(4)5)42-37(47)32(40-8)23(2)3)30(51-10)22-31(45)44-20-16-19-29(44)35(52-11)26(7)36(46)41-28(39(49)50)21-27-17-14-13-15-18-27/h13-15

Pharmacological characterization of 1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ-42041935)

CRISPR Editing Tool Box Catalog No.:LI30010-2S a multitargeted inhibitor of histoneProduct Information A very useful small molecule collection to improve CRISPR editing efficacy, 2 mg solid each for the following compounds: SCR7: a NHEJ inhibitor promotes the efficiency of HDR 45 fold for CRISPR editing in both human and mouse cell lines. RS 1: a RAD51 Stimulatory compound enhances CRISPR Cas9 and TALEN mediated knock in efficiency. (Z) 4 Hydroxytamoxifen: a previously characterised as an Estrogen Receptor antagonist and now found